posted
People are losing Focus, I haven't. Can't wait for the morning i wake up to a pr stating " XECHEM intl has recieved US FDA approval to market the drug in the united states...stock will gap up 1-200% depending on where it is.
IP: Logged |
some glaring needs addressed IMHO --------------------------------------------------- Xechem establishes Sickle Cell Advisory Board NEW BRUNSWICK, NJ – July 11, 2005 − Xechem International, Inc. (OTC BB: XKEM) Board of Directors today announced the establishment and charter membership of its Sickle Cell Research, Efficacy, Awareness and Marketing Advisory Board (the “Advisory Board”), which will assist Xechem’s management in creating public awareness of Xechem’s efforts to bring an effective treatment for Sickle Cell Disease to market in the United States and globally. The Advisory Board consists of distinguished individuals from the fields of pharmaceutical sales and marketing, urban marketing, international consulting, professional networking, entertainment, academia and business.
Members of the Advisory Board, identified below, may be asked from time to time to review and comment on Xechem’s business and marketing strategies with respect to obtaining approval from the United States Food and Drug Administration (US-FDA) for, and the commercial launch of, NIPRISAN (NICOSAN™) under the trade name HEMOXIN™ for the treatment of Sickle Cell Disease in the United States. The Advisory Board will function solely as an advisory body and does not have any legal oversight responsibilities with respect to Xechem or any legal authority to act on Xechem’s behalf. The names and brief biographical profiles of the charter members are set forth below.
VINCENT A. CARTER is an experienced pharmaceutical industry professional involved in the healthcare industry over the last nineteen (19) years. In 2004, Mr. Carter joined MedImmune, Inc., which manufactures a monoclonal antibody used in premature babies. Mr. Carter is an active member of the Healthcare Committee for One Hundred Black Men of New York.
DESIREE V. DELGADO is President and Chief Executive Officer of R2Network.net, Ltd. A DelzBrük Company, a general market media company offering a full-range of services to support the advertising, marketing and public relations process.
DR. GEORGE C. FRASER is Chairman and CEO of FraserNet, Inc., headquartered in Cleveland, Ohio, which is the publisher of the award-winning SuccessGuide Worldwide; The Networking Guide to Black Resources, which is published annually. Dr. Fraser is the author of two books, the critically acclaimed best sellers Success Runs In Our Race: The Complete Guide to Effective Networking in the African American Community and Race for Success: The Ten Best Business Opportunities for Blacks in America. Dr. Fraser spent seventeen (17) years in management with Procter & Gamble, United Way, and Ford Motor Company.
DR. GLENDA BASKIN GLOVER is the Dean of the School of Business at Jackson State University in Jackson, Mississippi. She is a Certified Public Accountant, an attorney and a higher education administrator. She holds a Ph.D. in economics and finance, and is one of two African American women to hold the economics Ph.D-CPA-JD combination in the nation.
DR. MARCELLUS GRACE has served as Professor of Pharmacy Administration and as the Associate Dean of the School of Pharmacy in the College of Pharmacy, Nursing and Allied Health Sciences at Howard University in Washington, DC since July 2004. He previously served as Dean and Professor of Pharmacy Administration in the College of Pharmacy at Xavier University of Louisiana in New Orleans, LA.
NADINE B. HACK is the Founder and President of beCause Global Consulting, Inc., which is a global consulting firm that conceives, develops, facilitates and executes the cause-related strategies and initiatives of corporate and nonprofit clients to build awareness of and support for humanitarian efforts. Ms. Hack has extensive experience with the United Nations, where she served as New York City Commissioner for the United Nations, Consular Corps and International Business, the city’s senior official liaison with the world’s largest diplomatic and business communities. The Boards on which she currently serves include the Desmond Tutu Peace Foundation (President), Africa-America Institute (Vice Chair), World Policy Institute, International League for Human Rights, and Synergos Institute. She has Master Degrees from the John F. Kennedy School of Government at Harvard University (MPA) and the Graduate Faculty of Political and Social Science at New School University (MALS).
J. WAYMAN HENRY III has over ten (10) years of experience in financial analysis, contract negotiations and marketing. He is Co-Founder and Vice President of Business Development of E-Merge International in Atlanta, GA, where he oversees all of the firm’s business operations in sports marketing, entertainment representation, National Football League apparel, event planning and intellectual property development.
WALLYE INESE HOLLOWAY is a Vice President and Account Group Supervisor of Cline Davis & Mann, a leading and award winning pharmaceutical marketing, brand development and advertising agency in New York City, where she has managed marketing and brand development strategies for large pharmaceutical companies, including Pfizer and Amgen since June 2002. Prior to joining Cline, Davis & Mann, Ms. Holloway worked in similar leadership capacities over a period of seven (7) years in New York City with several pharmaceutical marketing and brand management firms, including KPR, Sandler Science, Lowe McAdams Healthcare, and FCB Healthcare.
DR. STEPHEN H. KOLISON, JR. is the Dean and Research Director of the Institute of Agricultural and Environmental Research at Tennessee State University in Nashville, TN. His international experiences include research conducted in the Republic of Trinidad and Tobago, Jamaica, and Ghana, and other professional activities carried out in Belgium, Brazil, Finland, and The Netherlands. Dr. Kolison, Jr. obtained his Ph.D. and M.S. degrees in Forest Economics from Iowa State University of Science and Technology and his B.Sc. degree in General Forestry from the University of Liberia. In November 2004, Dr. Kolison assumed the role of Chair and Chief Executive Officer of the Association of Research Directors, Inc.
DR. KOFI LOMOTEY is a Senior Fellow at the American Association of State Colleges and Universities. He is the former President of Fort Valley State University in Fort Valley, GA. He was previously at Medgar Evers College of The City University of New York, where he was the Senior Vice President and Provost. Dr. Lomotey is the editor, co-editor or author of seven books and has published numerous articles and book chapters. Dr. Lomotey holds a B.A. degree from Oberlin College in Economics, a M.Ed. degree from Cleveland State University in Elementary Curriculum, and obtained his M.A. and Ph.D. degrees from Stanford University.
DR. TAMARA NEW is the Director of the Comprehensive Sickle Cell Center at Harlem Hospital Center in New York, NY. Dr. New also holds other leadership positions at Harlem Hospital Center, including Director of the Pediatric Residency Program, Director of the Pediatric Hematology-Oncology of Harlem Hospital Center and Clinical Director of the third year medical student Pediatric Clerkship program. Dr. New obtained her Doctor of Medicine degree from Mount Sinai School of Medicine, New York, NY and her BA in Chemistry from Smith College, Northhampton, MA.
DAKOTA PIPPINS is the Founder and CEO of Pippins Strategies, LLC, a marketing consulting firm that advises large corporations on strategies for attracting Urban consumers. Mr. Pippins is an Adjunct Assistant Professor at New York University where he previously served for five years as Director of NYU’s Management Institute and currently teaches a course on Urban Marketing Strategies. Mr. Pippins also serves on the Board of Directors of Hormel Foods Corp.
DR. MARCY STREET is the owner of Doctor’s Approach Dermatology & Laser Center in Lansing, MI, and is a Member of the Michigan Board of Medicine & Disciplinary Committee. Dr. Street has been in private practice since 1991 as a Medical Dermatologist, Skin Cancer Specialist and Mohs Surgeon with a CLIA approved Mohs surgery laboratory. Dr. Street is also a Clinical Instructor in Michigan State University’s Department of Internal Medicine, where she has lectured to medical students and residents on topics in general and surgical dermatology since 1991. Dr. Street received her M.D. from the University of Illinois College of Medicine in Chicago, IL.
Dr. Ramesh C Pandey, Chairman and CEO of Xechem said “we are very fortunate to have attracted such a knowledgeable and prestigious group of distinguished professionals and business leaders to help us in marketing NICOSAN™/HEMOXIN™ for the treatment of Sickle Cell Disease. We welcome the new Advisory Board members and are looking forward to the valued assistance we know they will offer us in bringing this extremely important drug into the hands of the millions of people who are suffering from this terrible disease.” About Xechem
Xechem is a development stage biopharmaceutical company engaged in the research development and production of niche generic and proprietary drugs from natural sources. Its principal product under development is NICOSAN™/HEMOXIN™, which has shown efficacy in the treatment of Sickle Cell Disease, according to Xechem’s public filings. Xechem is headquartered in New Brunswick, New Jersey.
For further information, contact the Company or Stephen Burg at 707-425-8855.
comments:
DESIREE V. DELGADO:
advertising, marketing and public relations process. NEED THIS
WALLYE INESE HOLLOWAY:
- award winning pharmaceutical marketing, brand development and advertising.
- she has managed marketing and brand development strategies for large pharmaceutical companies, including Pfizer and Amgen since June 2002. BIG NEED HERE
also: lots of African-American involvement, activism. this will be importatnt for this particular Disease, IMHO
--------------------------------------------------------- lunch time
quote:Originally posted by amswap: I make a general comment abouot some of the enormous egos on here and it gets removed. Yet someone can purposely try to start a problem and it remains? Allstocks is getting to an all new low now.
I think pennyhelper.com is the place to go from here. A new forum that won't allow this kind of personal attack to be tolerated, no matter how many posts the person has.
amswap, i really don't know what to tell you..
a few experinced traders have tried to HELP you guys with your obvious addiction/withdrawal situtation here and you guys keep peepeeing on them...
-------------------- Don't envy the happiness of those who live in a fool's paradise.
IP: Logged |
posted
htey posting news on their site so they dont hav eto pay prwire (since this event isnt huge, but important) save the pr wire for BIG news
IP: Logged |
posted
Glassman would you please expand on you last post I have been offerd help and I have taken it by people. So who has tried to help and if they are so great and we are so small as you infer why don't they just open there own post and if they were giving good advise the investor's would follow
IP: Logged |
quote:Originally posted by amswap: glass, I'm not the one who did anything here. Who asked who about a conscience? What is the purpose behind the personal digs? It seems that some get to say what they like and the rest aren't supposed to stand up to them. There was absolutely nothing productive or stock related to that. Why don't you point fingers where they belong?
------------------------------------------------- The finger should point to you..How much financial damage might you of caused by attacking the posters who tried to point out this stock was coming down!
How many people were confused by you? Again! Do you have a conscience!
IP: Logged |
posted
The only people that I have seen come in hear and this does not mean you glass came in with a bunch of personal insults and digs. Plus other forms of garbage that I don't find to interesting on a stock board. When nobdy listen much they got down rite rude when they were asked to please stop very nicley they attacked everybody here
IP: Logged |
quote:Originally posted by amswap: They have to wait until they find a stock going down to do that. At least that's all they did with this one. Not until last week did we even hear from most of the negative people, dare I say bashers. Right or wrong, they never offered advice before hand, only after it tanked. This isn't the only stock they've done this in. Guess it makes them feel good to say I told you so when they never did.
------------------------------------------------- Yes! it is easy to tell when a stock is coming down....
Why didn't you see it.
We did not give advice after it tanked, we gave advice at the top.
IP: Logged |
posted
FWIW having a conscience isn't the question. Go to the facts please. Unsupported run with "expected" news and "possible" outcomes and "hype", support levels were left in the dust around .03 even the candlesticks show empty flame all the way up. look how dark they are on the way back down. POP news, almost a redundant pr since it was already done. Hype is calling its bluff so to speak. If it would have been on CNN or national news in the US then IMO this would be already way up there. but it wasn't. Hype lost, back to support levels, candlesticks show resistance all the way down from people trying to average to get TF out. Day traders having a field day. and now here we are...another lesson learned.
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!?
IP: Logged |
posted
I admitt thatI made aterrible mistake and if a person would have came and given some good advise without a abunch of insults it most likley would have been recieved different and many would have been trading instead of fighting
IP: Logged |
posted
All are welcome here as far as I am concerned and if anybody has some good advice to help us I sure would listen to all sides as I always do but please for the good of all act like a pro when ytou give it and be a little more aware of peoples feelings inother words if somebody has a headache don't cure it by hitting them on the toe with a hammer
IP: Logged |
posted
i really should stay on the side lines, but IMO XKEM needs to put out a complete structure of what is going on, expeted revenue, current share structure, production capability, buyer support and status of future global sales. also it would be helpful to know just how the relation ship is set between XKEM Nigeria and XKEM US, who is benefiting where and by how much, if that has been in the filing I sure missed it. For me, getting those answers just might get me back in the game.
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!?
IP: Logged |
posted
sometimes? the worst thing that can happen to these companies is the runs are too big too fast and too many get burned, never to return.
if you guys beleive in this company? you want it to go up steady... 11 cent was INSANE....
that's all there is to it...
a few of you shoulda known better too...
like i said before ethnobaotanical cures and orphan drugs are important....
i am not here to say buy or sell, i am here to say that there's too much personal stuff going on and the few that are doin' it are just hurting themselves and allstocks and the comapny...
-------------------- Don't envy the happiness of those who live in a fool's paradise.
IP: Logged |
posted
You are right Glass things did get personal and it was the intruder that kept it that way even after the I am sorries went out to them. I think that that person until they grow up anyway should go where they are wanted.
IP: Logged |
posted
Phone man yes I do I think the threes are our bottom and then we bounce. Over 800 million shares were given to the MMs over the last six days this will stop when they can't get anymore then they most likly keep it in a trading range looks like they won this round anyway.
IP: Logged |
posted
bond006-you mentioned someone big may be intersted in this stock. I know you were just speculation. Now if they are working through someone like Quin to get this stock turned around while making a profit at the same time. Wouldn't a stronger stock price help tremendously with the funding Xechem needs to get going? Then the stock would really fly.
Just a thought. Everyone can laugh if they want to.
IP: Logged |
posted
I think you have a valid point and the stock price lies in the hands of everyone but the investor's who in a panic are giving them away to other people that will make money on there shares
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
